 |
|
|
FDA Requires Chantix to Have Mental Health Warning
FDA will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning.
|
|
0 Comments 
Posted Wednesday, July 1, 2009 --- 12:20 p.m.
NEW YORK (AP) -- The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.
The new requirement is based on reports of people experiencing unusual changes in behavior, becoming depressed, or having suicidal thoughts while taking the drug.
Pfizer Inc. had already updated the drug's labeling, following the beginning of an FDA investigation into the potential side effects in 2007.
The FDA is also requiring an additional study on the drugs to determine the extent of the side effects.
Copyright 2009 by The Associated Press. All Rights Reserved.
 |
Weather Authority
Watch your local weather 24/7. |
 |
|
 |
News Links
Looking for something you saw on NBC 15? Find it here. |
|
|
 |
Double Dollar Deals
Experience our area's best restaurants at a Half-Off price. |
|
|
 |
Golf Double Dollar Deals
Experience our area's best golf courses at a Half-Off price. |
|
|
 |
Family Double Dollar Deals
Experience our area's best businesses at a Half-Off price. |
|
|
 |
What's On?
Click here to see our program guide. |
|
|
 |
Perfect Home
Find out how to make your perfect home. |
|
|
 |
The Health Professional
Find answers to your health questions. |
|
|
 |
Madison's Biggest Loser
Click here! Find out how you can sign up and change your life! |
|
|
